miR-216 a may inhibit pancreatic tumor growth by targeting JAK 2

http://dx.doi.org/10.1016/j.febslet.2015.06.036 0014-5793/ 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. Abbreviations: 30-UTR, 30-untranslated region; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HRP, horseradish peroxidase; IL-10, interleukin-10; miRNA, microRNA; NC, negative control; PDAC, pancreatic ductal adenocarcinoma; PDT, photodynamic therapy; STAT, signal transducer and activator of transcription; TBS, Tris buffered saline Author contributions: Bao-hua Hou: guarantor of integrity of the entire study, study concepts, study design; Zhi-xiang Jian: definition of intellectual content; Peng Cui: literature research, manuscript preparation; Shao-jie Li: clinical studies, statistical analysis; Rui-qing Tian: manuscript editing; Jin-rui Ou: manuscript review. ⇑ Corresponding author at: Department of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan No. 2 Rd, Guangzhou 510080, PR China. Fax: +86 20 83827712. E-mail address: oujinrui@aliyun.com (J.-r. Ou). Bao-hua Hou, Zhi-xiang Jian, Peng Cui, Shao-jie Li, Rui-qing Tian, Jin-rui Ou ⇑

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy

  2014cited by this paper
• Alteration of the microRNA expression profile during the activation of pancreatic stellate cells

  2014cited by this paper
• MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.

  2013cited by this paper
• Report of incidence and mortality in China cancer registries, 2009.

  2013cited by this paper
• Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

  2013cited by this paper
• [Expression of miR-216a in pancreatic cancer and its clinical significance].

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Loss of miR-126 is crucial to pancreatic cancer progression

  2012cited by this paper
• Roles and Mechanisms of MicroRNAs in Pancreatic Cancer

  2011cited by this paper
• Natural orifice transluminal endoscopic surgery: new minimally invasive surgery come of age.

  2011cited by this paper
• Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma

  2011cited by this paper
• MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease

  2011cited by this paper
• Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells*♦

  2010cited by this paper
• Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

  2010cited by this paper
• Lestaurtinib, a multitargeted tyrosinse kinase inhibitor: from bench to bedside

  2010cited by this paper
• IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

  2010cited by this paper
• Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis

  2010cited by this paper
• Photodynamic therapy induces microRNA‐210 and ‐296 expression in HeLa cells

  2009cited by this paper
• Kinase drug discovery approaches in chronic myeloproliferative disorders

  2009cited by this paper
• Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.

  2009cited by this paper
• MicroRNAs: Novel Diagnostic and Therapeutic Tools for Pancreatic Ductal Adenocarcinoma?

  2009cited by this paper
• Causes and consequences of microRNA dysregulation in cancer

  2009cited by this paper
• Analysis of mortality rates for pancreatic cancer across the world.

  2008cited by this paper
• Mining for JAK-STAT mutations in cancer.

  2008cited by this paper
• MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

  2007influential reference
• Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

  2007cited by this paper
• JAK V617F missense mutation is absent in pancreatic cancer

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

  2006cited by this paper
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• MicroRNAs: a developing story.

  2005cited by this paper
• Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer.

  2005cited by this paper
• Combinatorial microRNA target predictions

  2005influential reference
• A unique clonal JAK 2 mutation leading to constitutive signalling causes polycythaemia

  2005cited by this paper
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

  2005cited by this paper
• Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.

  2005cited by this paper
• Human MicroRNA Targets

  2004cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

  2003cited by this paper
• Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury.

  2003cited by this paper
• STAT proteins: From normal control of cellular events to tumorigenesis

  2003cited by this paper
• Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.

  2002cited by this paper
• Cardiac-specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart

  2002cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• In vivo activation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSF

  2002cited by this paper
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• STAT signalling in cell proliferation and in development.

  2000cited by this paper

• Investigation of circRNA-miRNA-mRNA network in colorectal cancer using an integrative bioinformatics approach

  2021cites this paper
• Age-Related Pathways in Cardiac Regeneration: A Role for lncRNAs?

  2021influential citation
• STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance

  2018cites this paper
• بررسی بیان ژن JAK2 و MicroRNA-216a برروی بیماران مبتلا به لوسمی میلوئیدی حاد

  2018cites this paper
• Expression of JAK2 and MicroRNA-216a in Patients with Acute Myeloid Leukemia

  2018cites this paper
• LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a

  2018cites this paper
• miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-κB Signaling Pathway.

  2018cites this paper
• Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5.

  2017cites this paper
• The Role of Immune Modulatory MicroRNAs in Tumors

  2016cites this paper